XILIO THERAPEUTICS INC. - COMMON STOCK

Xilio Therapeutics to Present at the Citi 2023 Virtual Oncology Leadership Summit

16 фев 2023 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day

02 фев 2023 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics to Host Live Virtual Program Spotlighting XTX301, a Tumor-Activated IL-12

23 ноя 2022 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results

09 ноя 2022 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics to Present at Cowen 6th Annual ‘IO Next’ Summit

04 ноя 2022 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference

22 сен 2022 15:05:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics Appoints Tomas J. Heyman to Board of Directors

15 сен 2022 15:05:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference

06 сен 2022 15:05:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics Announces Encouraging Preliminary Phase 1 Dose-Escalation Data for XTX101, a Tumor-Selective Anti-CTLA-4, and Reports Pipeline and Business Updates and Second Quarter 2022 Financial Results

09 авг 2022 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President

16 июн 2022 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics to Present at the H.C. Wainwright Global Investment Conference

18 май 2022 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer

17 май 2022 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results

12 май 2022 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

07 апр 2022 05:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results

01 мар 2022 05:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics to Participate in the Cowen 42nd Annual Healthcare Conference

28 фев 2022 05:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics to Participate in the Guggenheim 4th Annual Oncology Day

03 фев 2022 05:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2 Clinical Trial of XTX202 for the Treatment of Patients with Solid Tumors

20 янв 2022 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors

06 янв 2022 06:30:00 Источник Nasdaq GlobeNewswire

Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results

02 дек 2021 06:30:00 Источник Nasdaq GlobeNewswire